RxDoctor Payments DataLook up a doctor →

Brian Steingo, MD

Neurology · Boca Raton, FLNPI 1417907163

Payments from drug & device makers

$4,635,076in general payments, 2019–2025

Across 1,956 payments — averaging $2369.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2.9M
  • Biogen$647K
  • Sanofi$597K
  • EMD Serono, Inc.$182K
  • AstraZeneca$103K
  • Genentech USA, Inc.$76K
  • plus $138K from 48 others
$27,497in research payments, 2019–2025

Across 33 payments — averaging $833.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$14K
  • Sanofi$7K
  • Novartis$6K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis251$2,891,865
Biogen340$647,318
Sanofi342$596,734
EMD Serono, Inc.273$182,199
AstraZeneca(2 entities)173$102,704
Genentech USA, Inc.124$76,290
Genentech, Inc.24$38,039
Bristol Myers Squibb54$30,770
Amgen(2 entities)20$27,125
E.r. Squibb & Sons, L.L.C.13$15,583
Johnson & Johnson64$14,465
Sanofi US Services Inc.2$4,531
TG Therapeutics, Inc.9$1,239
Teva Pharmaceuticals USA, Inc.46$1,128
ANI Pharmaceuticals, Inc.14$712
AbbVie(2 entities)43$699
UCB, Inc.17$416
Mallinckrodt Hospital Products Inc.10$355
Mallinckrodt Enterprises LLC14$318
Acorda Therapeutics, Inc15$270
Scilex Pharmaceuticals Inc.20$252
Octapharma USA, Inc.8$186
Argenx US, Inc.6$163
Neurocrine Biosciences, Inc.7$135
Vertical Pharmaceuticals, LLC2$127
Merz Pharmaceuticals, LLC5$127
Lundbeck LLC4$109
Takeda Pharmaceuticals U.S.A., Inc.3$109
Boston Scientific1$107
Lilly USA, LLC5$92
Vanda Pharmaceuticals Inc.5$83
Eisai Inc.4$75
Sunovion Pharmaceuticals Inc.4$74
Sanofi-aventis U.S. LLC5$73
CSL Behring2$57
Neurelis, Inc.3$55
Banner Life Sciences, LLC3$54
Acadia Pharmaceuticals Inc2$40
MDD US Operations, LLC2$40
SK Life Science, Inc.2$36
Life Molecular Imaging Ltd1$33
Insightec,inc1$33
Livanova USA, Inc.2$32
Aucta Pharmaceuticals, Inc.1$28
Amneal Pharmaceuticals LLC1$26
Tanabe Pharma America, Inc.1$25
Alnylam Pharmaceuticals Inc.1$24
Aprecia Pharmaceuticals, LLC1$22
Pfizer1$22
Inspire Medical Systems, Inc.1$20
Supernus Pharmaceuticals, Inc.1$20
Aquestive Therapeutics, Inc.1$17
Kyowa Kirin, Inc.1$16
Corium, LLC1$3

How this compares

$4,635,076 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024
$50,545
Medicare patients
182
Services billed
586

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Boca Raton

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →